Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Iranian missile strikes oil tanker in Qatar
Australia's Albanese says war's economic shock will be felt for months
Iranian drones target fuel tanks at Kuwait International Airport
At least 18 dead after migrant boat sinks off Turkey's Aegean coast
Trump says US to leave Iran 'very soon', will address nation Wednesday
Rubio says US can see 'finish line' on Iran war
Fire breaks out at company facility in Bahrain after Iranian attack
Tehran threatens US businesses, Hegseth says next few days 'decisive'
